{"id":581953,"date":"2025-07-03T22:57:41","date_gmt":"2025-07-04T05:57:41","guid":{"rendered":"https:\/\/nai500.com\/?p=581953"},"modified":"2025-07-03T22:57:41","modified_gmt":"2025-07-04T05:57:41","slug":"%e9%80%a2%e4%bd%8e%e5%b8%83%e5%b1%80%e8%bf%99%e4%b8%a4%e6%94%af%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1%e6%88%96%e8%bf%8e%e6%9d%a5%e8%bd%ac%e6%9c%ba","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2025\/07\/%e9%80%a2%e4%bd%8e%e5%b8%83%e5%b1%80%e8%bf%99%e4%b8%a4%e6%94%af%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1%e6%88%96%e8%bf%8e%e6%9d%a5%e8%bd%ac%e6%9c%ba\/","title":{"rendered":"\u9022\u4f4e\u5e03\u5c40\uff1a\u8fd9\u4e24\u652f\u751f\u7269\u79d1\u6280\u80a1\u6216\u8fce\u6765\u8f6c\u673a"},"content":{"rendered":"<p>\u5728\u5f53\u524d\u5e02\u573a\u6ce2\u52a8\u4e0b\uff0c\u90e8\u5206\u5177\u6709\u957f\u671f\u6f5c\u529b\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\u80a1\u4ef7\u5904\u4e8e\u4f4e\u4f4d\uff0c\u4e3a\u6295\u8d44\u8005\u63d0\u4f9b\u4e86\u9022\u4f4e\u4e70\u5165\u7684\u673a\u4f1a\u3002<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CRSP\">CRISPR Therapeutics\uff08CRSP\uff09<\/a>\u548c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VKTX\">Viking Therapeutics\uff08VKTX\uff09<\/a>\u8fd9\u4e24\u5bb6\u4e2d\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8\u867d\u7136\u8fc7\u53bb12\u4e2a\u6708\u8868\u73b0\u4e0d\u4f73\uff0c\u4f46\u4ecd\u6709\u503c\u5f97\u5173\u6ce8\u7684\u6295\u8d44\u4ef7\u503c\u3002<\/p>\n<h2>CRISPR Therapeutics\uff1a\u57fa\u56e0\u7f16\u8f91\u9886\u57df\u7684\u5148\u884c\u8005<\/h2>\n<p>CRISPR Therapeutics\u51ed\u501f\u5176\u57fa\u56e0\u7f16\u8f91\u836f\u7269Casgevy\u53d6\u5f97\u91cd\u5927\u7a81\u7834\uff0c\u8be5\u836f\u7269\u662f\u5168\u7403\u9996\u4e2a\u57fa\u4e8eCRISPR\u6280\u672f\u83b7\u6279\u7684\u7597\u6cd5\u3002\u5c3d\u7ba1\u516c\u53f8\u80a1\u4ef7\u81ea2021\u5e74\u8d77\u6301\u7eed\u4e0b\u8dcc\uff0c\u4f46\u672a\u6765\u4ecd\u5177\u53cd\u5f39\u6f5c\u529b\u3002<\/p>\n<p>\u80a1\u4ef7\u627f\u538b\u7684\u539f\u56e0\u5305\u62ec\uff1a<\/p>\n<ul>\n<li>\u4e34\u5e8a\u8fdb\u5c55\u540e\u7684\u83b7\u5229\u56de\u5410\uff1a\u5c0f\u578b\u751f\u7269\u79d1\u6280\u80a1\u5f80\u5f80\u5728\u53d6\u5f97\u91cd\u5927\u8fdb\u5c55\u540e\u906d\u9047\u6295\u8d44\u8005\u5957\u73b0\u3002<\/li>\n<li>\u5546\u4e1a\u5316\u8fdb\u7a0b\u8f83\u6162\uff1aCasgevy\u867d\u5df2\u83b7\u6279\uff0c\u4f46\u7531\u4e8e\u7ed9\u836f\u65b9\u5f0f\u590d\u6742\uff0c\u5c1a\u672a\u5bf9\u4e1a\u7ee9\u4ea7\u751f\u663e\u8457\u8d21\u732e\u3002<\/li>\n<li>\u5c1a\u672a\u76c8\u5229\uff1a\u5728\u5f53\u524d\u5e02\u573a\u73af\u5883\u4e0b\uff0c\u4e8f\u635f\u4f01\u4e1a\u66f4\u6613\u88ab\u4f4e\u4f30\u3002<\/li>\n<\/ul>\n<p>\u7136\u800c\uff0c\u516c\u53f8\u4ecd\u5177\u957f\u671f\u589e\u957f\u52a8\u529b\uff1a<\/p>\n<ul>\n<li>\u4e30\u5bcc\u7684\u7814\u53d1\u7ba1\u7ebf\uff1aCRISPR Therapeutics\u6b63\u5728\u5f00\u53d1\u9488\u5bf91\u578b\u7cd6\u5c3f\u75c5\u3001\u96be\u6cbb\u6027\u764c\u75c7\u7b49\u75be\u75c5\u7684\u521b\u65b0\u7597\u6cd5\uff0c\u672a\u6765\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u7684\u516c\u5e03\u53ef\u80fd\u63a8\u52a8\u80a1\u4ef7\u56de\u5347\u3002<\/li>\n<li>Casgevy\u7684\u5546\u4e1a\u6f5c\u529b\uff1a\u8be5\u836f\u7269\u5728\u7f8e\u56fd\u5b9a\u4ef7220\u4e07\u7f8e\u5143\/\u7597\u7a0b\uff0c\u76ee\u6807\u60a3\u8005\u7ea66\u4e07\u4eba\uff0c\u957f\u671f\u6765\u770b\u6709\u671b\u6210\u4e3a\u91cd\u78c5\u836f\u7269\u3002\u6b64\u5916\uff0c\u516c\u53f8\u4e0eVertex Pharmaceuticals\u7684\u5408\u4f5c\u964d\u4f4e\u4e86\u5546\u4e1a\u5316\u98ce\u9669\uff0c\u5e76\u63d0\u4f9b\u4e86\u7a33\u5b9a\u7684\u73b0\u91d1\u6d41\u652f\u6301\uff08\u622a\u81f3\u7b2c\u4e00\u8d22\u5b63\u672b\uff0c\u73b0\u91d1\u50a8\u5907\u8fbe18.6\u4ebf\u7f8e\u5143\uff09\u3002<\/li>\n<\/ul>\n<h2>Viking Therapeutics\uff1a\u80a5\u80d6\u75c7\u6cbb\u7597\u9886\u57df\u7684\u9ed1\u9a6c<\/h2>\n<p>Viking Therapeutics\u6b64\u524d\u56e0\u6297\u80a5\u80d6\u836f\u7269VK2735\u7684II\u671f\u4e34\u5e8a\u6570\u636e\u8868\u73b0\u5f3a\u52b2\u800c\u80a1\u4ef7\u5927\u6da8\uff0c\u4f46\u968f\u540e\u56de\u843d\u3002\u5c3d\u7ba1\u5982\u6b64\uff0c\u8be5\u516c\u53f8\u4ecd\u5177\u5438\u5f15\u529b\uff0c\u539f\u56e0\u5982\u4e0b\uff1a<\/p>\n<ul>\n<li>\u6297\u80a5\u80d6\u836f\u7269\u5e02\u573a\u5feb\u901f\u589e\u957f\uff1aVK2735\u7684\u4e2d\u671f\u6570\u636e\u4f18\u4e8e\u591a\u6570\u7ade\u54c1\uff0c\u4e14\u516c\u53f8\u8fd8\u5728\u5f00\u53d1\u53e3\u670d\u5236\u5242\uff0c\u8fdb\u4e00\u6b65\u62d3\u5c55\u5e02\u573a\u6f5c\u529b\u3002<\/li>\n<li>\u591a\u5143\u5316\u7684\u7814\u53d1\u7ba1\u7ebf\uff1a\u9664VK2735\u5916\uff0cViking\u7684VK2809\uff08\u6cbb\u7597\u8102\u80aa\u6027\u809d\u708e\uff09\u5373\u5c06\u8fdb\u5165III\u671f\u4e34\u5e8a\uff0c\u800cVK0214\uff08\u6cbb\u7597\u7f55\u89c1\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff09\u5df2\u83b7FDA\u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\u3002<\/li>\n<\/ul>\n<p>\u4f5c\u4e3a\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0cViking\u82e5\u906d\u9047\u8bd5\u9a8c\u632b\u6298\uff08\u5c24\u5176\u662fVK2735\uff09\uff0c\u80a1\u4ef7\u53ef\u80fd\u5927\u5e45\u6ce2\u52a8\u3002\u4f46\u82e5\u80fd\u987a\u5229\u63a8\u8fdb\u7814\u53d1\uff0c\u5e02\u503c\uff08\u76ee\u524d\u4ec530\u4ebf\u7f8e\u5143\uff09\u6709\u671b\u663e\u8457\u63d0\u5347\u3002<\/p>\n<h2>\u7ed3\u8bba<\/h2>\n<p>\u5c3d\u7ba1CRISPR\u548cViking\u77ed\u671f\u5185\u9762\u4e34\u5e02\u573a\u538b\u529b\uff0c\u4f46\u51ed\u501f\u521b\u65b0\u6280\u672f\u548c\u4e30\u5bcc\u7684\u7814\u53d1\u7ba1\u7ebf\uff0c\u957f\u671f\u6295\u8d44\u4ef7\u503c\u4ecd\u7136\u7a81\u51fa\u3002\u5bf9\u4e8e\u80fd\u591f\u627f\u53d7\u6ce2\u52a8\u7684\u6295\u8d44\u8005\u800c\u8a00\uff0c\u5f53\u524d\u4f4e\u4f4d\u6216\u662f\u5e03\u5c40\u826f\u673a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5728\u5f53\u524d\u5e02\u573a\u6ce2\u52a8\u4e0b\uff0c\u90e8\u5206\u5177\u6709\u957f\u671f\u6f5c\u529b\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\u80a1\u4ef7\u5904\u4e8e\u4f4e\u4f4d\uff0c\u4e3a\u6295\u8d44\u8005\u63d0\u4f9b\u4e86\u9022\u4f4e\u4e70\u5165\u7684\u673a\u4f1a\u3002CRISPR Th [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":581954,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,747,925],"class_list":["post-581953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-747","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/581953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=581953"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/581953\/revisions"}],"predecessor-version":[{"id":581961,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/581953\/revisions\/581961"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/581954"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=581953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=581953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=581953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}